Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

The Court of Appeal has upheld a British watchdog's 99 million pound ($131.94 million) fine against owners of Advanz Pharma ...

Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...

The European drugs regulator said on Thursday its safety committee has confirmed suicidal thoughts as a side effect of Organon's anti hair-loss drug finasteride, following an EU-wide review of ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Hikma Pharmaceuticals has agreed to pay $50 million to settle a class action accusing the drugmaker of scheming to delay a generic version of Jazz’s blockbuster narcolepsy drug Xyrem, causing health ...

Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.